Steve Shevel, Associate, has been with Waife & Associates, Inc. since 2008. He has 15 years of experience in all phases of clinical study team operations. Beginning as a CRA with Quintiles and then as Senior CRA at Eli Lilly, Mr. Shevel worked in a dozen therapeutic areas, including CNS, oncology, diabetes, ophthalmology and medical devices. Steve then worked as a Clinical Operations Manager and study team leader at Pfizer, AstraZeneca, GlaxoSmithKline and Allergan.

When Mr. Shevel joined W&A from Allergan, he was Associate Director of eSolutions, a role in which he was responsible for leading assistance to the company's clinical study teams in transitioning to full use of EDC, ePRO, IVRS and CTMS technologies.

Besides providing representation for W&A on the West Coast, Mr. Shevel provides its clients particular expertise in ePRO (electronic patient-reported outcomes) study implementations, IXRS, eClinical vendor management, and assistance with eClinical study team transitions.

Mr. Shevel earned his undergraduate degree in microbiology and genetic
engineering at UC Santa Barbara, and his MBA from UC Irvine. He staffs the W&A office in Southern California.